En Español | Members Area

PhRMA at work.

Industry Profile

Industry Profile

By engaging in cutting-edge scientific research and the development of new technologies, America's biopharmaceutical companies lead the world in the search for new cures to the most debilitating and deadly diseases.

This year's Pharmaceutical Industry Profile offers insights into the research and development (R&D) process that PhRMA members engage in and the outcomes its complex pathways produce.

Annual Report

Annual Report

Issues

Disease is our common enemy. America’s research-based pharmaceutical companies are global leaders in creating new cures and treatments to help patients fight disease. Learn more about the issues affecting the fight against disease and determining whether patients can get the medicines they need.

The pharmaceutical business is unlike any other, Our goal is not entertainment, enjoyment or prosperity. It is the health of patients. PhRMA member companies are devoted to applying biomedical innovation to create new medicines that will enhance or save the lives of patients around the world.

Being in the healthcare business brings awesome responsibilities. Every day, our member companies face difficult, fundamental questions. The answers to those questions profoundly affect patients’ lives. Which diseases should we study? How can we best advance research? Where is the balance between risk and benefit?

Answering these questions wisely requires that we make decisions that benefit society for the long-term and that put patients’ interests first. Our companies were built on the values of honor, commitment, integrity and responsibility – values that put the needs of patients first. These values, which have taken this industry so far for so long, must be the values that drive us today.

- William C. Weldon, Immediate Past Chairman

Medicare


more

Importation


The Dangers of Prescription Drug Importation

The recent headlines tell it all: contaminated dog food, toy products laced with lead paint and unsafe tires from overseas. Does it make sense then for Congress to consider legislation allowing for prescription ...

more

FDA Issues

Read selected PhRMA comments and other submissions to FDA and other government agencies. This is not intended to provide a complete listing of all PhRMA submissions; in addition, certain submissions may be available in other parts of the PhRMA website.

more

Research and Development

Everyone with questions about the flu or avian flu should be able to get the answers they need easily and quickly. America's research-based pharmaceutical companies are working actively in partnership with the U.S. Government and world health officials to make sure that patients ...

more

Direct to Consumer Advertising

PhRMA member companies understand that accurate information about disease and treatment options makes patients and doctors better partners. And getting that information to doctors and patients is the goal of Direct-to-Consumer (DTC) prescription medicine advertising.

DTC advertising increases people's ...

more

Value of Medicines

The value of new and better medicines stems not only from the improved treatment of disease, but also from a reduction in other health care costs, increased productivity and better quality of life.

more

Prescription Drug Costs

Prescription drugs are the best value in health care - saving lives, reducing pain and suffering, keeping people out of hospitals and nursing homes, and reducing other forms of health care spending.

more

Intellectual Property

Pharmaceutical companies rely on government-granted patents to protect their huge investments in researching and developing new drugs. It takes 10-15 years and costs $800 million on average to bring a new medicine to market.

Without patents to protect all the inventions necessary to develop ...

more